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Cyclin D-Cdk4 complexes have a demonstrated role in
G1 phase, regulating the function of the retinoblastoma
susceptibility gene product (Rb). Previously, we have
shown that following treatment with low doses of UV
radiation, cell lines that express wild-type p16 and Cdk4
responded with a G2 phase cell cycle delay. The UV-
responsive lines contained elevated levels of p16 post-
treatment, and the accumulation of p16 correlated with
the G2 delay. Here we report that in UV-irradiated HeLa
and A2058 cells, p16 bound Cdk4 and Cdk6 complexes
with increased avidity and inhibited a cyclin D3-Cdk4
complex normally activated in late S/early G2 phase.
Activation of this complex was correlated with the caf-
feine-induced release from the UV-induced G2 delay and
a decrease in the level of p16 bound to Cdk4. Finally,
overexpression of a dominant-negative mutant of Cdk4
blocked cells in G2 phase. These data indicate that the
cyclin D3-Cdk4 activity is necessary for cell cycle pro-
gression through G2 phase into mitosis and that the
increased binding of p16 blocks this activity and G2
phase progression after UV exposure.
Loss of normal cell cycle control mechanisms is a common
theme in the development of most cancers, in particular the
loss of mechanisms involved in sensing and repairing DNA
damage. An increasing number of tumor suppressor genes have
been found to be intimately involved in DNA damage re-
sponses, including cell cycle responses. The best documented of
these are the tumor suppressor genes TP53 and Rb. TP53 is
mutated in a high proportion of tumors, and its gene product
(p53) is involved in cell cycle responses following DNA damage
(1). p53 knockout mice develop relatively normally, but are
prone to a range of tumors (2). Rb was identified as the retino-
blastoma susceptibility gene, and its gene product (Rb) has a
pivotal role in the late G1 phase restriction point (3). Knockout
of one allele of Rb in mice produced animals predisposed to
pituitary tumors, but they did not develop retinoblastoma, and
the homozygous knockout was embryonically lethal (4). These
tumor suppressors exert their cell cycle effects by ultimately
modulating the levels and activities of the regulatory elements
underlying cell cycle progression, the cyclin-dependent kinases.
The cyclin-dependent kinases are regulated in a complex
manner, through cyclin subunit association; a series of tightly
regulated phosphorylations and dephosphorylations (5); and
the binding of inhibitory protein subunits, CKI proteins (Cdk
inhibitors) (6). p53 can directly regulate the expression of one of
these CKI proteins, p21 (1); and in response to DNA damage,
p53-induced p21 expression is responsible for a G1 phase delay
(7). Fibroblasts from p21 knockout mice fail to delay in G1 in
response to similar damage (8). The mechanism by which Rb
exerts its cell cycle inhibitory effects is somewhat complex,
although this is largely via its ability to bind and inhibit the
activity of a group of transcription factors (E2F) that are es-
sential for progression into S phase and the expression of a
number of positive and negative regulators of cell cycle pro-
gression (3). Thus, loss of Rb function would be predicted to
result in a deregulation of entry into S phase. One of the cell
cycle regulators whose expression is controlled by Rb function
is itself a tumor suppressor, p16CDKN2A. p16 is another CKI
that acts specifically to inhibit cyclin D-Cdk4 and Cdk6, the
cyclin-dependent kinases responsible for phosphorylating Rb
during G1 (3, 6). CDKN2A itself is mutated, deleted, or hyper-
methylated in a high proportion of human tumors (9). CDKN2A
has also been identified as a melanoma susceptibility gene (10)
and is deleted, mutated, or hypermethylated in a high propor-
tion of melanoma cell lines (10).
Cell cycle responses to DNA damage induced by suberythe-
mal doses of UV radiation include both G1 and G2 phase delays.
G1 delays appear to be through a p53-dependent mechanism,
with increased expression of p21 resulting in inhibition of G1
cyclin/cyclin-dependent kinases (11–13). The G2 delay is p53-
independent and is via a block in the Cdc25-dependent activa-
tion of cyclin A-Cdk and cyclin B-Cdc2 complexes (14, 15). Cells
undergoing the UV-induced G2 delay appear to be identical to
normal early G2 phase cells, and in many respects, the delay
appears to be a prolongation of that cell cycle state (15). The
cells recover from the UV-induced block after a delay of 24 h
and recommence normal proliferation (16). A major difference
that has been noted between the UV-induced G2-delayed cells
and normally cycling cells at the equivalent cell cycle stage was
a large increase in the level of p16 protein (17). Analysis of a
number of mainly melanoma cell lines either deleted for
CDKN2A or that expressed either mutant p16 or Cdk4 showed
that only cells lines that expressed both wild-type p16 and
Cdk4 displayed a UV-induced G2 delay (16). Of the melanoma
cell lines that had lost their UV-induced G2 delay response, two
expressed p16 with mutations that abolished Cdk4 (but not
Cdk6) binding, and one line expressed the Cdk4 R24C muta-
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tion, which abrogated p16 binding (10, 16, 17). This suggested
that the effects of p16 on the G2 delay were being mediated
through Cdk4, the most likely mechanism being p16 binding
and inhibition of a cyclin D-Cdk4 activity. Here we show the
existence of a cyclin D3-Cdk4 activity in late S/G2 phase cells
that is inhibited in response to UV radiation through the in-
creased association of p16 and provide evidence that this Cdk4
activity is necessary for normal G2 phase cell cycle progression.
MATERIALS AND METHODS
Cell Culture and Metabolic Labeling—The HeLa (human cervical
carcinoma) and human melanoma A2058 cell lines were cultured in
RPMI 1640 medium supplemented with 5 and 10% Serum Supreme
(BioWhittaker, Inc.), respectively. For synchrony experiments, the cell
lines were blocked overnight with 2 mM thymidine and then released
into fresh medium containing 24 mM thymidine and deoxycytidine. S
phase cell-enriched populations were obtained by harvesting at 4 h
after release, and late S/G2 phase cell-enriched populations at 8 h after
release. Mitotically enriched populations were collected when .30% of
cells showed the rounded mitotic phenotype. Asynchronous cultures
were irradiated with 10 J m22 UVC in 2 ml of prewarmed phosphate-
buffered saline and then refed fresh medium. G2-delayed cells were
obtained by harvesting at 24 and 20 h post-irradiation for HeLa and
A2058 cells, respectively. The cell cycle status was confirmed by flow
cytometry of the DNA content. See Fig. 1 for typical cell cycle profiles of
the synchronized and UV-irradiated cultures.
Synchronized and UVC-irradiated cells were metabolically labeled
with 0.3 mCi/ml 35S-Promix (Amersham Pharmacia Biotech) in methi-
onine- and cysteine-free medium for 2 h, chased in complete medium for
the indicated times, washed twice with phosphate-buffered saline, and
harvested. Synchronized late S/G2 phase cells or UV-irradiated cells (24
h post-irradiation) were metabolically labeled with 1 mCi/ml 32Pi in
phosphate-free medium for 3 h or, in the case of caffeine release, labeled
for 2 h and then a further 1 h after caffeine addition. Cells were washed
twice with phosphate-buffered saline, harvested, and processed as de-
scribed below for immunoprecipitation.
Immunoprecipitation and Immunoblotting—Cells were lysed in
NETN buffer (100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, and 20
mM Tris, pH 8) supplemented with 150 mM NaCl, 5 mg/ml aprotinin, 5
mg/ml pepstatin, 5 mg/ml leupeptin, 0.5 mM phenylmethylsulfonyl fluo-
ride, 10 mM NaF, and 0.1 mM sodium orthovanadate. The cleared
supernatants were immunoprecipitated using anti-p16 (17), anti-cyclin
A (Pharmingen), anti-cyclin B1 (18), or anti-Cdk4 or anti-Cdk6 (Santa
Cruz Biotechnology) antibody with protein A-Sepharose. Immunopre-
cipitates from metabolically 32P- and 35S-labeled samples were resolved
on 15% SDS-polyacrylamide gel and autoradiographed or quantitated
by a PhosphorImager (Molecular Dynamics, Inc.). Other immunopre-
cipitates were immunoblotted for associated proteins using the indi-
cated antibody. Cyclin D3 was detected using two specific monoclonal
antibodies (Pharmingen G107-565 and Oncogene Research Products Ab
2).
Cdk4 immunoprecipitate Rb kinase assays were performed in a sim-
ilar manner to that described elsewhere (19). Briefly, cell pellets (1–5 3
106 cells) were lysed in 50 mM Hepes, pH 7.5, 1 mM EDTA, 2.5 mM
EGTA, 1 mM dithiothreitol, 250 mM NaCl, 10% glycerol, 0.1% Tween 20,
1 mM sodium fluoride, 0.1 mM sodium vanadate, and protease inhibitors
as described above for 1 h on ice with occasional vortexing. The lysates
were precleared with 30 ml of a 50% suspension of protein A-Sepharose
for 30 min, and the cleared supernatants were incubated with 1 mg of
anti-Cdk4 or anti-p16 antibody for 2–3 h and then precipitated by the
addition of 20 ml of a 50% suspension of the protein A-Sepharose for an
additional 1 h. The precipitates were washed four times with the lysis
buffer and then twice with the kinase buffer, and the kinase assay was
performed with the addition of 30 ml of reaction mixture containing 50
mM Hepes, pH 7.5, 10 mM MgCl2, 50 mM ATP, 1 mM dithiothreitol, and
1–3 mg of purified GST1-Rb-(773–923) and 10 mCi of [g-32P]ATP for 30
min. The reactions were stopped by the addition of SDS sample buffer
and boiled for 2 min, and then the total reaction was separated on 10%
SDS-polyacrylamide gel, stained with Coomassie Blue, dried, and au-
toradiographed. Cyclin B1 kinase assays were performed as described
previously (15). The activity of the immunoprecipitated kinases was
quantitated by phosphoimaging of the phosphorylated GST-Rb-(773–
928) and histone H1 bands.
Transient Transfections—Expression constructs containing hemag-
glutinin (HA)-tagged wild-type Cdk4 and Cdk6 and the dominant-
negative Cdk4 D158N and Cdk6 D163N mutants (10 mg/107 cells) (20)
were transfected by electroporation into HeLa cells. Cdk4 and Cdk6
were cotransfected with mouse CDC37 (10 mg/107 cells) (21). Cells were
harvested 48 h post-transfection, and overexpression of Cdk4 or Cdk6
was assessed by staining with anti-Cdk4 or anti-Cdk6 antibody de-
tected with a fluorescein-labeled secondary antibody and DNA stained
with propidium iodide and then analyzed by two-parameter flow cytom-
etry (18). Cells expressing elevated levels of Cdk4 or Cdk6 were ana-
lyzed for their DNA content for cell cycle status.
Gel Filtration Analysis—Control unirradiated cells (either asynchro-
nous or synchronized late S/G2 phase) or UV-irradiated G2-delayed cells
were lysed in NETN buffer as described above, and the cleared super-
natant (2 mg of protein) was applied to a Superose 12 column (Amer-
sham Pharmacia Biotech) equilibrated in 20 mM Tris, pH 8, 2 mM
EDTA, 1 mM dithiothreitol, and 150 mM NaCl. The column was devel-
oped by fast protein liquid chromatography (Amersham Pharmacia
Biotech) at a flow rate of 0.25 ml/min, and 0.5-ml fractions were col-
lected. Fractions were either immunoblotted for p16, Cdk4, Cdk6, or
cyclin D3 or immunoprecipitated with anti-p16 and anti-Cdk4 antibod-
ies and then analyzed by immunoblotting.
RESULTS
Increased p16-Cdk4 and p16-Cdk6 Complex Stability follow-
ing UV Exposure—We have previously reported elevated levels
of p16 in response to low dose UV radiation, which correlated
with G2 phase cell cycle delay (16, 17). Here we have investi-
gated the consequences of p16 accumulation in two cell lines:
HeLa cells, which are human pappiloma virus-transformed
epithelial cells derived from an adenocarcinoma, and A2058
cells, derived from a malignant melanoma. The following ex-
periments were conducted in both cell lines with essentially
identical results, and consequently, only the data obtained with
HeLa cells are shown in most cases.
To identify proteins associated with p16 in HeLa and A2058
cells, [35S]Met/Cys-labeled cells were lysed, and p16-associated
complexes were immunoprecipitated and analyzed by SDS-
polyacrylamide gel electrophoresis. Three bands were specifi-
cally precipitated with the antibody in both control and UV-
1 The abbreviations used are: GST, glutathione S-transferase; HA,
hemagglutinin.
FIG. 1. Fluorescence-activated cell sorter profiles of HeLa cell
cycle distribution of asynchronous (AS), thymidine block re-
lease synchronized S (S) and late S/G2 (G2), and UV-irradiated
cultures 24 h post-exposure (UV).
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irradiated HeLa cells (Fig. 2A), which were identified by
immunoblotting as p16, Cdk4, and Cdk6 (Fig. 3A). No other
35S-labeled bands were found to be specifically associated with
p16 in either control or UV-irradiated samples. p53 accumula-
tion following DNA damage involves an increase in p53 protein
stability (22), and 35S pulse-chase experiments were performed
to investigate whether the UV-induced accumulation of p16
utilized a similar mechanism. There was little difference in the
half-life of p16 in asynchronously growing and UV-irradiated
G2-delayed A2058 and HeLa cultures, although p16 had a
shorter half-life in A2058 cells (6 h; n 5 1) compared with HeLa
cells (9.5 6 0.5 h; n 5 3) (Fig. 2, B and C). Unexpectedly, the
half-life of Cdk4 and Cdk6 associated with the p16 immuno-
precipitates increased markedly (2–3-fold) in the UV-irradiated
cells compared with unirradiated controls in both cell lines.
The half-life of the p16-Cdk4 complex increased from 5 6 1 h in
the control HeLa cells to 12 6 1 h in the UV-irradiated cells
(n 5 3). The increased half-life of the p16-Cdk6 complex was
similar, although the very low levels of Cdk6 in HeLa cells
precluded accurate estimates. The increased half-life of p16-
Cdk4 and p16-Cdk6 in control cells compared with irradiated
A2058 cells was similar, from 2 to 3 h to 10 to 14 h, respectively.
This was not due to any increase in the half-life of the Cdk4 and
Cdk6 proteins themselves (Fig. 2C), but suggested a decrease
in the rate of exchange of newly synthesized p16-bound Cdk4
and Cdk6 with the unlabeled pools of Cdk4 and Cdk6, reflect-
ing an increase in the stability of the p16-Cdk4 and p16-Cdk6
complexes following UV radiation. Although asynchronously
growing cultures were used as controls in these experiments,
pulse-chase data from synchronized G2 cell-enriched cultures
gave essentially the same results (data not shown).
UV Radiation Increases p16 Association with Cdk4 and Cy-
clin D—The association of p16 with Cdk4 and Cdk6 was fur-
ther investigated by immunoblotting. In HeLa cells, the levels
of Cdk4 and Cdk6 were unchanged throughout the cell cycle or
following UV radiation, whereas p16 levels increased .4-fold
following UV radiation (Fig. 3A), as shown previously (16, 17).
The sole cyclin D partner for Cdk4 in HeLa cells, cyclin D3,2
was also expressed at a constant level in these samples. The
very low level of cyclin D3 associated with Cdk4 was confirmed
by immunoblotting with two separate anti-cyclin D3 mono-
clonal antibodies (see “Materials and Methods”). When Cdk4
immunoprecipitates from these same cell lysates were immu-
noblotted for cyclin D3, no change in the level of this protein
was apparent, whereas the level of p16 associated with Cdk4
increased in the UV-irradiated sample, paralleling the increase
in total p16 levels (Fig. 3B). Immunoblotting of p16 immuno-
precipitates from similar lysates also showed constant levels of
cyclin D3 associated with p16 in each sample and no change
in the Cdk4 levels associated with p16 in the UV-irradiated
cells (Fig. 3C), in contrast to the Cdk4-associated p16 levels
(Fig. 3B).
To further investigate the p16-Cdk4-cyclin D3 complexes,
UV-irradiated and control HeLa cultures were lysed and frac-
tionated on a Superose 12 gel filtration column, and the frac-
tions were immunoblotted for p16, Cdk4, Cdk6, or cyclin D3.
p16 eluted as two distinct peaks; the level of p16 eluting in the
higher Mr peak increased .4-fold in the UV-irradiated sample
compared with the control, whereas the increased level of p16
in the lower molecular weight peak was more modest, ;2-fold
(Fig. 4, A and B). Cdk4 eluted as a broad peak from fractions 13
to 20, and Cdk6 eluted as a tighter peak around fraction 15,
whereas the majority of the cyclin D3 was associated with very
high molecular weight complexes, peaking in fraction 4, al-
though very low levels were detected through to fraction 14
(data not shown). The distribution of Cdk4, Cdk6, and cyclin
D3 did not change discernibly between control (either asyn-
chronous or synchronized late S/G2 phase cultures) and UV-
irradiated samples. The p16 and Cdk4 complexes in these
fractions were analyzed by sequential immunoprecipitation
2 X. Q. Wang and B. G. Gabrielli, unpublished observations.
FIG. 2. UV radiation increases the stability of the p16-Cdk4
and p16-Cdk6 complexes. A, lysates of either control asynchronous or
UV-irradiated G2-delayed HeLa cells metabolically labeled with
[35S]methionine and cysteine were immunoprecipitated with either an-
ti-p16 antibody or antibody preincubated with the immunogen peptide,
and the immunoprecipitates were analyzed on 15% SDS-polyacryl-
amide gel. The positions of p16, Cdk4, and Cdk6 are indicated. B and C,
shown are the relative levels of 35S-labeled p16, Cdk4, and Cdk6 asso-
ciated with p16 immunoprecipitates during a pulse-chase experiment of
labeled A2058 and HeLa cultures. D, shown are the levels of 35S-labeled
Cdk4 and Cdk6 immunoprecipitated with their respective antibodies
from the same HeLa pulse-chase experiment as C. The intensity of the
labeled bands is in arbitrary units. con, control.
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with anti-p16 antibody under conditions that immunodepleted
p16 and then immunoprecipitated with anti-Cdk4 antibody to
examine the Cdk4 complexes not containing p16. Both p16 and
Cdk4 immunoprecipitates were immunoblotted for p16, Cdk4,
and cyclin D3. p16 immunoprecipitates of the gel filtration
fractions revealed that p16 was present in three different com-
plexes: with cyclin D3 and Cdk4 (fractions 13–15), a complex
with Cdk4 only (fractions 17–19) (Fig. 4, C and D), and a
monomer, as p16 immunoprecipitates from fractions 20–22
contained no Cdk4 or Cdk6 (data not shown). The level of cyclin
D3, Cdk4, and p16 detected in the p16 immunoprecipitate from
fraction 13 was increased 2-fold in the UV-irradiated sample
compared with the late S/G2 phase control (Fig. 4, C and D).
Reciprocal Cdk4 immunoprecipitation and p16 immunoblot-
ting of equivalent fractions in a separate experiment revealed
the same increase of the p16-Cdk4-cyclin D3 complex in UV-
irradiated samples (data not shown). Cdk4 immunoprecipitates
from the p16-immunodepleted fractions (demonstrated by the
absence of detectable p16 in the Cdk4 immunoprecipitates)
(Fig. 4C) revealed a higher level of cyclin D3 associated with
Cdk4 (fractions 13 and 15) in the control compared with the
irradiated samples. The relative intensity of the Cdk4 and
cyclin D3 bands in the p16 and Cdk4 immunoprecipitates in-
dicated that the majority of Cdk4 and cyclin D3-Cdk4 was
associated with p16, with only small pools of cyclin D3-Cdk4
and Cdk4 (fraction 17, anti-Cdk4 immunoprecipitate) (Fig. 4C)
not associated with p16, and that these free pools were reduced
following UV exposure (Fig. 4C).
In an effort to identify novel p16-containing complexes in
either control or UV-irradiated cells, earlier eluting, higher
molecular weight fractions (fractions 1–4 and 5–8) were
pooled, and the presence of p16 was examined by immunopre-
cipitating with anti-p16 antibody from the pooled fractions and
immunoblotting with the same antibody. No p16 was detected
in the earlier eluting fractions from either control or irradiated
samples.
A Cdk4 Activity in Late S/Early G2 Phase Is Inhibited fol-
lowing UV Radiation—The previous experiments showed that
a consequence of the increased p16 levels in the UV-irradiated
cells was an increase in the p16-Cdk4-cyclin D3 complex. This
suggested that cyclin D3-Cdk4 may be active in the late S/early
G2 phase of normally cycling cells and inhibited in the UV-
irradiated G2-delayed cells. The presence of such an activity
was assessed in HeLa cell cultures synchronized using a thy-
midine block/release protocol. Cells were collected at times up
to 14 h post-release as they progressed from G1/S through
mitosis into the next G1 phase (Fig. 5). Cdk4 activity at each
time point was examined using a Cdk4 immunoprecipitate
kinase assay with GST-Rb-(733–928) as a substrate. A kinase
activity associated with the Cdk4 immunoprecipitates was de-
tected as cells commenced entering G2 phase (6 h), peaked at
8 h, and then decreased again as the cells existed mitosis (11 h).
The peak of activity correlated with the shoulder of p9CKSHs1-
Sepharose-precipitable H1 kinase activity in G2, prior to the
major peak of H1 kinase activity in mitosis (10 h). The immu-
noprecipitated kinase activity was shown to be due to a Cdk4
complex, as nonreactive serum or immune peptide-blocked an-
ti-Cdk4 antibody immunoprecipitated only background Rb ki-
nase activity from late S/G2 phase HeLa cell lysates, and no
phosphorylated bands were detected in immunoprecipitates
assayed without addition of the Rb substrate (Fig. 6A). Fur-
thermore, the Cdk4-associated activity was not inhibited by 50
mM olomoucine, a strong inhibitor of Cdk2 and Cdc2 kinases,
but relatively ineffective against Cdk4 (23), which resulted in
80% inhibition of immunoprecipitated Cdk2 activity (Fig. 6, A
and B). When the Cdk4 activity in UV-irradiated G2-delayed
samples was tested, it was found to be inhibited in both HeLa
and A2058 cells when compared with the respective cell cul-
tures enriched for S, late S/G2, and M phase cells (Fig. 6C). In
HeLa cells, Cdk4 activity was decreased by 60% in the UV-
irradiated cells compared with the G2 cell-enriched cultures
(Fig. 6D).
Activation and Phosphorylation of Cdk4 Are Correlated with
Exit from UV-induced G2 Delay—We have previously shown
that the UV-induced G2 phase delay results in a block in the
Cdc25-dependent activation of the mitotic cyclin-Cdk com-
plexes in G2 and M (15). Here we have demonstrated that the
normal activation of cyclin D3-Cdk4 in early G2 phase was
inhibited during the UV-induced G2 delay and that cyclin D3-
Cdk4 activation occurred in G2 prior to the activation of cyclin
B-Cdc2 at the G2/M transition (Fig. 7A). This suggested a
possible causal relationship between cyclin D3-Cdk4 activation
and the activation of the cyclin-Cdk complexes later in G2. This
relationship was examined in UV-irradiated HeLa cells in-
duced to progress through the G2 delay into mitosis with 5 mM
caffeine (24), and the activities of Cdk4 and cyclin B1 kinases
were measured. Addition of caffeine resulted in a rapid exit
from the G2 delay, and cells commenced accumulating in G1 by
2 h following caffeine addition (Fig. 7B). Cdk4 activity was
almost maximal within 1 h following caffeine addition to the
culture medium and then started to decline by 3 h, whereas
cyclin B1-Cdc2 activity was not maximal until 3 h following
caffeine addition (Fig. 7C). Thus, the block of Cdk4 activation
was relieved by the addition of caffeine, was correlated with
FIG. 3. Level of p16 associated with Cdk4 increases following
UV exposure. Shown are the levels of cyclin D3, Cdk4, Cdk6, and p16
in total lysates (A), associated with anti-Cdk4 (B) or anti-p16 (C) im-
munoprecipitates, and from synchronized or UV-irradiated HeLa cell
cultures. The specificity of the Cdk4 and cyclin D3 association with p16
was demonstrated by preincubating anti-p16 antibody with the im-
munogen peptide (UV 1 pep).
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continued progression through G2, and preceded cyclin B1-
Cdc2 activation at the G2/M transition.
We earlier demonstrated that the level of p16 associated
with Cdk4 increased in UV-irradiated cells (Fig. 3B). The bind-
ing of p16 to Cdk4 complexes after caffeine release was exam-
ined to see whether the activation of Cdk4 correlated with
decreased p16 association. By 1 h post-caffeine addition, the
increased level of p16 associated with Cdk4 complexes in the
UV-irradiated cells had returned to control levels, correlating
with the activation of cyclin D3-Cdk4 (Fig. 7, C and D). The
levels of p16 did not change discernibly during this time (data
not shown) (16), indicating that the reduced binding of p16 is
not simply due to reduction in the level of p16.
The phosphorylation status of Cdk4 was examined to deter-
mine whether the activation of Cdk4 might involve a phospho-
rylation event. Cdk4 immunoprecipitates from metabolically
32Pi-labeled HeLa cells, either UV-irradiated G2-delayed cells
or at 1 h post-caffeine addition, revealed a 1.8-fold increase in
the phosphorylation of Cdk4 (Fig. 8A). Interestingly, p16 im-
munoprecipitates from equivalent samples did not contain any
labeled bands, although immunoblotting of 10% of these im-
munoprecipitates for Cdk4 showed that all contained similar
levels of Cdk4 protein (data not shown). In a separate experi-
ment, a 2-fold difference in the phosphorylation state of Cdk4
was observed in Cdk4 immunoprecipitates from UV-irradiated
and synchronized late S/G2 cells (Fig. 8B). Again, no labeled
bands were detected in anti-p16 immunoprecipitates. No phos-
phorylation of p16 was detected under any condition.
Cdk4 Activity Is Required for Progression through G2 into
Mitosis—The data presented suggest a role for Cdk4 activity in
cell cycle progression through early G2 into mitosis. To directly
test whether Cdk4 is involved in cell cycle progression, the
dominant-negative Cdk4 D158N mutant was overexpressed in
HeLa cells, and the cell cycle status of the overexpressing
population was assessed by flow cytometry. Experiments using
the equivalent mutants of Cdc2 and Cdk2 have demonstrated
the cell cycle transitions regulated by these cyclin-dependent
kinases (20). To obtain sufficiently high levels of Cdk4 overex-
pression for the mutant to exert a dominant-negative effect, the
Cdk4 was cotransfected with mouse CDC37, which increased
FIG. 4. Increased levels of p16 bound to cyclin D3-Cdk4 com-
plexes after UV exposure. Asynchronous control (2UVC) or UV-
irradiated G2-delayed (1UVC) HeLa cell lysates were fractionated on a
Superose 12 gel filtration column, and the indicated column fractions
were immunoblotted for p16 (A). The level of p16 in the fractions was
quantitated by laser densitometry of the immunoblots (B). In C, control
synchronized late S/G2 phase (G2) or UV-irradiated (UV) HeLa cell
lysates were fractionated as described for A. Equivalent fractions were
sequentially immunoprecipitated with anti-p16 and then anti-Cdk4
antibodies, and the immunoprecipitates (IP) were immunoblotted for
cyclin D3 (cyc D3), Cdk4, and p16. The anti-p16 and anti-Cdk4 immu-
noprecipitates were exposed together for the same period to demon-
strate the relative levels of Cdk4 and cyclin D3 complexed with p16 and
not associated with p16. The upper band in the UV-treated cyclin D3
blot is cross-reactive IgG heavy chain. The shorter exposure of the
immunoblots shown in C shows the relative increase in cyclin D3 and
p16 levels in anti-p16 immunoprecipitates from UV compared with
control samples (D).
FIG. 5. A Cdk4 activity is present in normally cycling late S/G2
phase cells. HeLa cells were synchronized in early S phase with a
thymidine block and then released. Cells were harvested at the indi-
cated times after release and analyzed for cell cycle status by flow
cytometry and for Cdk4 activity by Cdk4 immunoprecipitate kinase
assay using GST-Rb-(773–928) (GT-Rb) as substrate or for Cdk2 and
Cdc2 kinase activity precipitated by p9CKSHs1-Sepharose using histone
H1 as substrate.
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the stability of the overexpressed Cdk4 protein (21). Cotrans-
fection of Cdk6 with CDC37 had little effect on Cdk6 expres-
sion, as reported previously (21). Immunoblotting for Cdk4 and
Cdk6 revealed that wild-type and mutant versions of both
proteins were strongly expressed, with the ectopically ex-
pressed proteins being distinguishable from the endogenous
forms due their slightly retarded electrophoretic mobility, a
result of the HA tag (Fig. 9A). Cells overexpressing Cdk4 and
Cdk6 were discriminated on the basis of increased Cdk4 or
Cdk6 staining using flow cytometry, and the cell cycle distri-
bution of the overexpressing population was determined. The
wild-type Cdk4-overexpressing population showed a small in-
crease in the G2/M population compared with control vector-
transfected cells, but the mutant-overexpressing cells showed a
1.5-fold accumulation of G2/M phase cells over the wild type-
overexpressing cells (Fig. 9B). Inspection by immunofluores-
cent microscopy of transfected cells stained for ectopic Cdk4
expression (HA tag) and endogenous cyclin B1 showed that a
higher proportion of cells strongly overexpressing the Cdk4
mutant contained high levels of cytoplasmic cyclin B1, an in-
dicator of G2 phase (25), compared with the untransfected
population, indicating that mutant Cdk4 overexpression re-
sulted in accumulation of G2 phase cells. As a further control
for the specificity of Cdk4 action, wild-type and dominant-
negative mutant forms of Cdk6 were also transfected into HeLa
cells. Cells overexpressing either form of Cdk6 produced a cell
cycle profile similar to that produced by the wild-type Cdk4-
overexpressing cells. Thus, the increased accumulation of G2
phase cells observed with mutant Cdk4 overexpression was due
FIG. 6. G2 phase Cdk4 activity is inhibited in UV-irradiated
G2-delayed cells. A, late S/G2 phase HeLa cell lysates were immuno-
precipitated with nonimmune serum (NI) or anti-Cdk4 or anti-Cdk2
antibody, and the immunoprecipitates were assayed either with or
without substrate and 50 mM olomoucine (Olo.) as indicated. B, the level
of Cdk4 and Cdk2 immunoprecipitate activity is expressed as a per-
centage of the minus-olomoucine control. C, Cdk4 immunoprecipitate
Rb kinase activity from the indicated synchronized and UV-irradiated
HeLa and A2058 cells is shown. D, the Cdk4 Rb kinase activity in
UV-irradiated or control late S/G2 phase HeLa cells is expressed as a
percentage of the control from four separate experiments. GT-Rb,
GST-Rb-(773–928).
FIG. 7. Caffeine-induced release from the G2 phase delay is
correlated with increased Cdk4 activity and decreased p16
binding. A, shown is the cyclin B1 and Cdk4 immunoprecipitate kinase
activity from asynchronous (AS), UV-irradiated G2-delayed (UV), late
S/G2 (G2), and mitotically enriched (M) HeLa cells. Phosphorylated
GST-Rb-(773–928) is indicated (arrowhead). B, UV-irradiated G2-de-
layed HeLa cultures were treated with 2 mM caffeine (time 0), the cells
were harvested at the indicated times, and their DNA content was
analyzed by flow cytometry for cell cycle status. C, lysates from equiv-
alent samples were assayed for Cdk4 and cyclin B1 immunoprecipitate
kinase activity (C). The activities are expressed as a percentage of their
peak activity. D, the level of p16 bound to Cdk4 from asynchronous,
UV-irradiated G2-delayed, and UV-irradiated cultures either 1 or 3 h
post-caffeine (caff.) addition was assessed by immunoblotting anti-Cdk4
immunoprecipitates for Cdk4 (as a loading control) and p16.
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to the specific inhibition of a Cdk4-dependent activity and
provides further evidence for a Cdk4-dependent step in G2
phase cell cycle progression.
DISCUSSION
Cyclin D-Cdk4 complexes have been reported to exist
throughout the cell cycle in many cell types (26, 27), although
the function of these complexes through the cell cycle, apart
from regulating the Rb-dependent G1 checkpoint, is unknown.
Here we have demonstrated that cyclin D3-Cdk4 complexes are
present throughout the cell cycle and that this complex is
activated in late S/early G2 phase in both HeLa and A2058
cells. The presence of a Cdk4 activity in G2 phase was first
indicated by Matsushime et al. (27), who showed, in mouse
fibroblasts overexpressing Cdk4 and cyclin D, peaks of Cdk4
activity both in G1 and G2 cell-enriched fractions. In the cell
lines tested here, little G1 phase Cdk4 activity was detected
(the low level of Cdk4 activity immunoprecipitated from lysate
of asynchronous cultures represents Cdk4 activity from .60%
G1 phase cells). The absence of G1 phase Cdk4 activity in
Rb-defective cell lines, a consequence of human pappilloma
virus-E7 expression in HeLa cells and loss of Rb expression in
A2058 cells,2 has been reported by others (28, 29).
The high levels of heterodimeric p16-Cdk4 and p16-Cdk6
complexes and monomeric p16 detected in HeLa and A2058
cells are also a common feature of Rb-defective cell lines (30,
31). In both HeLa and A2058 cells, only a small proportion of
Cdk4 associated with cyclin D3, in agreement with other stud-
ies that showed that high levels of p16 expression reduce cyclin
D binding to Cdk4 (30, 31).
In response to UV exposure, p16 association with Cdk4 is
elevated, presumably a result of both increased p16 levels and
the increased stability of p16-Cdk4 and p16-Cdk6 complexes. A
clear consequence of the increased association of p16 with Cdk4
complexes is the inhibition of cyclin D3-Cdk4 activity. This was
correlated with decreased phosphorylation of Cdk4 compared
with either normal early G2 phase cells or cells released from
the UV-induced block with caffeine. The phosphorylation de-
tected is likely to be at the activating Thr-172 on Cdk4 cata-
lyzed by CAK (32), which has been demonstrated to be blocked
by p16 in vitro (33). The absence of phosphorylated Cdk4 in p16
immunoprecipitates fits well with the proposal that the in-
creased p16 association is inhibiting Thr-172 phosphorylation
of Cdk4 and thereby blocking its activation.
The observed UV-induced increase in the stability of the
p16-Cdk4 and p16-Cdk6 complexes is unexpected. A recent
mutational analysis of Cdk4 examining residues involved in
p16 binding may provide a mechanism by which this increased
FIG. 8. UV exposure decreases the phosphorylation of Cdk4. A,
UV-irradiated HeLa cells 22 h post-exposure were labeled for 2 h with
32Pi in phosphate-free medium; 5 mM caffeine (caff) was added to half
the plates and incubated an additional 1 h, and the cells were then
harvested. Lysates prepared from these samples were initially incu-
bated with nonimmune serum (NI) and then either anti-Cdk4 or anti-
p16 antibody. The immunoprecipitates were washed and analyzed on
15% SDS-polyacrylamide gel. The position of 32P-labeled Cdk4 is indi-
cated (arrowhead). B, cultures of UV-irradiated cells 22 h post-exposure
and synchronized late S/G2 phase cells containing similar numbers of
cells were labeled for 3 h and processed as for A. In this experiment, the
UV sample was incubated with anti-p16 antibody or with anti-p16
antibody preincubated with the p16 peptide to block immunoreactivity
(see Fig. 2A). The positions of molecular weight markers (3103) are
shown, and the 32P-labeled Cdk4 band is indicated (arrowhead).
FIG. 9. Overexpression of a dominant-negative form of Cdk4
produces a G2 phase delay. A, HeLa cells were transiently trans-
fected with either a control vector (SRa con) or vector containing the
indicated HA-tagged wild-type (wt) or dominant-negative mutant
(D/N) Cdk4 or Cdk6 cDNA. Cells were harvested and immunoblotted
with anti-Cdk4 and anti-Cdk6 antibodies. The ectopically expressed
proteins are distinguished from the endogenous versions by their
slower electrophoretic mobility due the HA tag. B, cells transfected as
described for A were stained with either anti-Cdk4 or anti-Cdk6 anti-
body detected with a fluorescein-labeled secondary antibody and with
propidium iodide for DNA. The Cdk4- and Cdk6-overexpressing cells
were gated as the cells with elevated fluorescein signal over the empty
vector control levels (Cdk expression), and the DNA content of the gated
overexpressing population (population above the cutoff on dot plots on
the left) is shown in the histograms on the right. The vector control is
the total DNA histogram. The percentages of cells in each cell cycle
stage are mean 6 S.D. from three separate experiments.
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complex stability is acquired. This study demonstrated that
mutation of Thr-172 to the nonphosphorylatable Ala residue
increased p16 binding .2-fold (34). The crystal structure of the
p16-Cdk6 complex revealed the T-loop containing Thr-172 to lie
close to the first ankyrin repeat of p16 (35), and the presence of
a highly charged phosphoryl group at Thr-172 is likely to alter
the binding avidity of p16. Our findings that increased p16
binding correlated with decreased Cdk4 phosphorylation in
UV-irradiated cells and that decreased p16 binding following
caffeine-induced release from the G2 block correlated with in-
creased Cdk4 phosphorylation support a mechanism where a
decrease in Cdk4 Thr-172 phosphorylation may increase p16
binding, which in turn will block the rephosphorylation of
Thr-172 by CAK. It is not clear how caffeine changes the
balance of phosphorylation and p16 binding so rapidly, and this
whole mechanism will require further study.
The decreased phosphorylation of Cdk4 during the G2 delay
following UV exposure, in particular the absence of any phos-
phorylation of p16-bound Cdk4, differentiates this Cdk4-de-
pendent cell cycle block from a Cdk4-dependent G1 phase block
also initiated by low dose UV radiation (36). It was demon-
strated that Cdk4 was phosphorylated at Tyr-17 in response to
UV radiation of cells in early G1 phase and that this blocked G1
phase progression (36). However, this mechanism appeared to
be specific for the G1 block, and cells expressing wild-type Cdk4
or a nonphosphorylatable Cdk4 Y17F mutant were equally
susceptible to DNA damage and displayed similar survival
when irradiated as they entered S phase, suggesting that later
cell cycle checkpoints did not utilize this mechanism.
A lot of attention has been given to the role of cyclin D-Cdk4
complexes in regulating the G1 phase Rb function, and there is
currently little evidence of a role for these complexes later in
the cell cycle. Much of the work on cyclin D has focused on
cyclin D1, and although there is some degree of functional
redundancy between the D-type cyclins, it becoming evident
that all D-type cyclins are not equivalent. For example, over-
expression of cyclin D1 (but not cyclin D3) accelerated G1
progression in fibroblasts (27), and overexpression of cyclins D2
and D3 (but not cyclin D1) inhibited granulocyte differentiation
(37). In estrogen-stimulated MCF-7 breast cancer cells, cyclin
D1 transcript and protein levels correlated with G1 phase pro-
gression, whereas expression of cyclin D3 message and protein
was delayed, with cyclin D3 protein reaching maximal levels as
cells progressed into G2 phase (19). Substrate specificity differ-
ences have also been found between the cyclin D1-Cdk4 and
D3-Cdk4 complexes in vivo and in vitro (38). Thus, it is likely
that different cyclin D-Cdk4 complexes may have distinct func-
tions, dependent on the cell type in which they are expressed
and the timing of their expression and activation during the
cell cycle.
The existence of a G2 phase cyclin D-Cdk4 activity would also
imply a regulatory mechanism to control this activity. The
constitutive presence of the cyclin D3-Cdk4 complex through-
out the cell cycle precludes cyclin-Cdk complex formation; thus,
activity must be regulated at the level of phosphorylation
and/or CKI interaction, which may act in concert to ensure very
tight regulation. Agents or conditions that increase CKI levels
at a particular point in the cell cycle presumably utilize these
inhibitors to block cell cycle progression beyond that point until
this inhibition is relieved. There are many reports demonstrat-
ing that overexpression of p16 inhibits cyclin D-Cdk4-depend-
ent phosphorylation of Rb and G1 phase progression (29, 39, 40)
and proliferation in an Rb-dependent manner (29, 41, 42).
Small increases in endogenously expressed p16 protein were
found as serum-stimulated cells entered S phase (43) and at the
S/G2 transition in synchronized HeLa cells (17), although these
were not correlated with discernible cell cycle delays. Much
larger increases in p16 levels have been found in senescing
cells, correlating with inhibition of the G1 and S phase cyclin/
cyclin-dependent kinases (44), and as a delayed response to low
doses of UV radiation, correlating with a G2 delay (16, 17) and
inhibition of cyclin D3-Cdk4 (this report). The UV-induced
elevated p16 levels appear to be a specific response to UV-
induced damage, as other genotoxic agents that produce a G2
delay in HeLa and A2058 cells, e.g. cisplatin and ionizing
radiation, do not affect p16 protein levels.3 Interestingly, a
recent report has provided evidence for a p16-dependent check-
point in G1 in response to a wide variety of DNA-damaging
agents in p53-deficient cell lines (45). This checkpoint is de-
pendent on Rb and Cdk4, although the levels of p16 appeared
unchanged in this response, differentiating it from the UV
response investigated here, which appears to be independent of
Rb function.
The data reported here provide evidence for a cyclin D-Cdk4
activity in late S/G2 phase that appears to be required for
normal cell cycle progression through G2 phase into mitosis.
This Cdk4 activity is inhibited in response to UV radiation, and
inhibition of this activity appears to be involved in the G2 phase
delay observed. It will be of interest to see whether this role for
p16 in a G2 checkpoint is UV-specific or a more general cell
cycle checkpoint control. It may also provide a mechanistic
basis for the strong genetic and epidemiological evidence link-
ing UV radiation, p16CDKN2A function and melanoma.
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